Evidence map›Paper›PMID 40267030›Full record

ArticleThe journal of physical chemistry. B2025

Interplay of Hydrophobicity, Charge, and Sequence Length in Oligopeptide Coassembly.

Subhadra Thapa, Anshul Gahlawat, Severin T Schneebeli, Jianing Li

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Subhadra ThapaBorch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907, United States.
Anshul GahlawatBorch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907, United States.
Severin T SchneebeliDepartment of Industrial and Physical Pharmacy and Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0002-9511-9922
Jianing LiBorch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0002-0143-8894

Funding

Robust Sequence-defined Nanocages with Protein-mimetic CavitiesR35GM147579 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Severin Thomas Schneebeli · 2022 to 2026
$1.9M
Precision Design of Antimicrobial Peptides Against Bacterial InfectionsR01GM143370 · NIGMS · PURDUE UNIVERSITY · PI LI, JIANING · 2022 to 2025
$1.2M
NIGMS NIH HHS R01 GM143370NIGMS NIH HHS R35 GM147579
6 · The paper itself

Abstract

Peptide coassembly offers novel opportunities for designing advanced nanomaterials. This study used coarse-grained molecular dynamics simulations to examine the coassembly of charge-complementary peptides, assessing various ratios and the role of charge and hydrophobicity in their aggregation. We discovered that peptide length, charge, and hydrophobicity significantly influence coassembly behavior, with more hydrophobic peptides exhibiting greater aggregation despite electrostatic repulsion. Beyond the coassembly of two peptides, we also observed that the coassembly of more than two peptides will likely lead to new assembly structures and properties. Our findings underscore the importance of peptide composition and length in tuning the coassembly and the resulting properties, thus facilitating the design of complex peptide nanoparticles for biomedical and biotechnological applications.

Indexed as

OligopeptidesAmino Acid SequenceHydrophobic and Hydrophilic InteractionsMolecular Dynamics SimulationStatic ElectricityOligopeptides

Identifiers

PMID40267030
PMCPMC12186690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.